Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01342796
Recruitment Status : Completed
First Posted : April 27, 2011
Last Update Posted : August 30, 2012
Information provided by (Responsible Party):
Novartis ( Novartis Vaccines )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : February 2012
  Certification/Extension First Submitted : August 23, 2012